About Alta Pharmaceutical Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Mannkind Corporation
7
Arrowhead Pharmaceuticals
2
NewAmsterdam Pharma
2
Pfizer
2
Bristol-Myers Squibb
1
Kowa Research Institute, Inc.
1
Swedish Orphan Biovitrum
1
Clinical Trials at Alta Pharmaceutical Research Center
During the past decade, Alta Pharmaceutical Research Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
2005-06-01
2008-10-01
Completed
2,053
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
2006-02-01
2008-09-01
Completed
677
Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
2006-06-01
2007-10-01
Terminated
3
Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler
2010-09-01
2012-03-01
Terminated
39
Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
2010-10-01
2012-03-01
Terminated
3
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Alta Pharmaceutical Research Center" #1 sponsor was "Mannkind Corporation" with 7 trials, followed by "Arrowhead Pharmaceuticals" with 2 trials
sponsored, "NewAmsterdam Pharma" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bristol-Myers Squibb"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alta Pharmaceutical Research Center"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Alta Pharmaceutical Research Center
According to Clinical.Site data, the most researched conditions in "Alta Pharmaceutical Research Center" are
"Atherosclerotic Cardiovascular Disease" (2 trials), "Cardiovascular Disease" (2 trials), "Dyslipidemias" (2 trials), "Type 2 Diabetes" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Alta Pharmaceutical Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Alta Pharmaceutical Research Center
Most popular intervention types in "Alta Pharmaceutical Research Center" are "Drug" (16 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Technosphere® Insulin Inhalation Powder" (3 trials), "ARO-APOC3" (2 trials), "Obicetrapib" (2 trials) and "Technosphere Insulin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Alta Pharmaceutical Research Center
The vast majority of trials in "Alta Pharmaceutical Research Center" are
16 trials for "All" genders.
Clinical Trials Status at Alta Pharmaceutical Research Center
Currently, there are NaN active trials in "Alta Pharmaceutical Research Center".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 5 completed trials in Alta Pharmaceutical Research Center,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Alta Pharmaceutical Research Center, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".